Related Experiment Videos

[Hyperbilirubinemia in normal neonates]

Ceskoslovenska Pediatrie
|March 1, 1989
PubMed

Insights

Neonatal hyperbilirubinemia (high serum bilirubin) affects 17.7% of healthy newborns, with 5.3% requiring phototherapy. This study highlights significant increases in these conditions and individual variations in bilirubin metabolism adaptation.

Area of Science:

  • Neonatology
  • Pediatric Endocrinology
  • Clinical Chemistry

Context:

  • Investigated a cohort of 13,449 neonates with birth weights ≥2500g.
  • Excluded neonates with Rh or ABO blood group incompatibility.
  • Monitored serum bilirubin levels and phototherapy treatment over a ten-year period.

Purpose:

  • To analyze the incidence and trends of neonatal hyperbilirubinemia and phototherapy.
  • To identify demographic factors, such as sex, associated with hyperbilirubinemia.
  • To explore individual variations in bilirubin metabolism adaptation in healthy term neonates.

Summary:

  • A significant rise in serum bilirubin (>205 µmol/l) was observed in 17.7% of neonates, with 5.3% receiving phototherapy.
  • The frequency of hyperbilirubinemia and phototherapy demonstrated a significant increasing trend over the ten-year study duration.
  • Boys were significantly predominant among neonates with hyperbilirubinemia and those undergoing phototherapy.
  • Serum bilirubin level development showed considerable individual variations in pattern, peak value, and timing, indicating diverse adaptation rates of bilirubin metabolism.

Impact:

  • Provides crucial data on the prevalence and trends of neonatal jaundice in a large cohort.
  • Highlights the significant role of sex in the occurrence of hyperbilirubinemia.
  • Emphasizes the wide range of individual variability in bilirubin metabolism, even in healthy term infants.
  • Informs clinical practice regarding monitoring and management of neonatal hyperbilirubinemia.

Related Concept Videos